Utah Medical Products
UTMD
96 hedge funds and large institutions have $299M invested in Utah Medical Products in 2019 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 27 increasing their positions, 44 reducing their positions, and 5 closing their positions.
10% more capital invested
Capital invested by funds: $273M → $299M (+$26.4M)
0% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 5
1% less funds holding
Funds holding: 97 → 96 (-1)
1.97% less ownership
Funds ownership: 76.49% → 74.52% (-2%)
39% less repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 44
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Russell Investments Group
London,
United Kingdom
|
+$1.68M |
| 2 |
ProShare Advisors
Bethesda,
Maryland
|
+$421K |
| 3 |
State Street
Boston,
Massachusetts
|
+$376K |
| 4 |
Morgan Stanley
New York
|
+$352K |
| 5 |
RHJA
Rice Hall James & Associates
San Diego,
California
|
+$228K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$1.53M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.46M |
| 3 |
MDCM
Morgan Dempsey Capital Management
Menomonee Falls,
Wisconsin
|
-$819K |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$798K |
| 5 |
TAM
THB Asset Management
Norwalk,
Connecticut
|
-$700K |
UTMD Hedge Fund Activity: Q4 2019 in Review
96 of the 5,076 institutional investors tracked by Wall St. Rank reported a position in Utah Medical Products (UTMD) for Q4 2019, worth a combined $299M — up 9.7% from $273M a quarter earlier.
Fund positioning in UTMD was balanced in Q4 2019: 5 funds opened new positions, 5 closed out, 27 added to existing stakes and 44 trimmed.
The largest buyer was Russell Investments Group, adding an estimated $1.68M. The largest seller was Vanguard Group, cutting an estimated $1.53M.
- 96 institutional investors held Utah Medical Products (UTMD) as of Q4 2019, down from 97 in Q3 2019.
- Funds reported $299M of Utah Medical Products stock for Q4 2019, up 9.7% quarter-over-quarter.
- 5 funds opened new Utah Medical Products positions in Q4 2019 and 5 closed out, a net change of 0 holders.
- The largest Utah Medical Products buyer in Q4 2019 was Russell Investments Group, an estimated $1.68M added.
- The largest Utah Medical Products seller in Q4 2019 was Vanguard Group, an estimated $1.53M sold.
Based on aggregated 13F filings for Q4 2019.